Next Comm Convo Announced: Fluent in Finance, Science, and Strategy
|
Hi! One of the themes that came through at our recent Biopharma Comms Forum (more on that soon!) is that clarity comes in part from understanding the business deeply enough to see what matters, what is changing, and where the pressure points are before they become visible to everyone else. That's the focus of our June Comm Convo: Fluent in Finance, Science, and Strategy.🗓️ Tuesday, June 30th What we’ll exploreThis conversation will look at what it takes for communicators to operate with real fluency across the business, and to shape the counsel, sharpen the narrative, and influence decisions at the right altitude. We'll be looking at:
Featured speakers💬 Naina Bhasin, Ph.D., Chief Operating Officer, Lifordi Immunotherapeutics 💬 Julie DiCarlo, Head of Investor Relations & Communications, Rapport Therapeutics 💬 Chris Patil, Ph.D., Vice President, Media, BioAge Labs 💬 Peggy Vorwald, Ph.D., Executive Director, IR and Corporate Communications, Caribou Biosciences (Moderator) Together, they’ll bring perspectives from company building, investor relations, science, media, operations, and corporate communications to a conversation about how fluency across the business changes the work, the relationships, and the level of counsel communicators can provide. Hope to see you there! Lynnea P.S. - If you're at BIO or local to San Diego, please swing by our reception tomorrow near the convention center (BIO pass not needed)! |
T2B Monthly
T2B Monthly | June 2026 Hi! You tell me. Are we creating magic? That's how one of our forum speakers summed up T2B. To pursue a career as a biopharma communicator requires intention, grit, and high EQ. So, despite working in an industry steered by data, I'd agree that convening this community (all of you!) – across coast-to-coast meetups, our second annual forum, member-led virtual sessions – is a privilege, and yes, a little magical. ✨ Today's email is 2,604 words, a 9-minute read. In this...
Hi! A reminder that tomorrow’s June Comm Convo will explore how life science communicators "speak" finance, science, and strategy, and what that fluency informs in our work. June Comm Convo: Fluent in Finance, Science, and Strategy 📅 Tuesday, June 30th (tomorrow!)⏰ 12-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. BST📍 Zoom🎟️ RSVP here. Complimentary for T2B Pro and Student members / $40 for Basic members. Please note that this will definitely not be a “finance and science 101” session. We’ll focus on...
Hi! You don't need me to tell you that there's an ongoing, major, major shift in healthcare media. One of the most prominent changes we're seeing right now is more journalists leaving traditional newsrooms to launch independent newsletters, podcasts, and subscriber-supported publications of their own. For us communicators, that raises important questions: How are reporters finding stories? What does credibility look like outside traditional media brands? How are these new publications going...